首页> 外文OA文献 >Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries

【2h】

Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries

机译：将成本和结果的不确定性与获得孤儿药品的需求相协调：对七个欧洲国家/地区管理性入境协议的比较研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries [J] . Thomas Morel, Francis Arickx, Gustaf Befrits, Orphanet Journal of Rare Diseases . 2013,第1期

机译：将成本和结果的不确定性与获得孤儿药品的需求相协调：对七个欧洲国家/地区管理性入境协议的比较研究
2. Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries [J] . Thomas Morel, Francis Arickx, Gustaf Befrits, Orphanet journal of rare diseases . 2013,第2期

机译：成本和结果的不确定性与获得孤儿药品的需求之间的协调：对七个欧洲国家/地区管理性入境协议的比较研究
3. Rationalizing the introduction and use of pharmaceutical products: The role of managed entry agreements in Central and Eastern European countries [J] . Rotar Alexandru M., Preda Alin, Loblova Olga, Health policy . 2018,第3期

机译：合理化药品的介绍和使用：管理入境协议在中欧和东欧国家的作用
4. EXPLORING A METHODOLOGY TO ASSESS COUNTRIES' PREPAREDNESS PRACTICES - OUTCOMES FROM A COMPARATIVE ANALYSIS OF THE EUROPEAN AND NORTH AMERICAN APPROACHES [C] . Marlene Calderon Veiga International oil spill conference (IOSC 2008) . 2008

机译：探索评估国家防备措施的方法-通过对欧洲和北美方法的比较分析得出的结果
5. Quasi-experimental study to determine the impact of parallel trade and external reference pricing strategies utilized by the European Union (EU) on the rate of drug approval launches and patient access to U.S. designated fast track drugs and orphan drugs. [D] . King, Josephine G. 2008

机译：一项准实验研究，旨在确定欧盟（EU）使用的平行贸易和外部参考定价策略对药物批准投放率和患者使用美国指定的快速通道药物和孤儿药物的速度的影响。
6. Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries [O] . Thomas Morel, Francis Arickx, Gustaf Befrits, 2013

机译：将成本和结果的不确定性与获得孤儿药品的需求相协调：对七个欧洲国家/地区管理性入境协议的比较研究
7. PSY81 Managed Entry Agreements and Orphan Drugs: A European Comparative Study (2006-2012) [O] . Morel T., Arickx F., Befrits G., 2013

机译：PSY81受管入境协议和孤药：欧洲比较研究（2006-2012年）

Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries

著录项

相似文献

相关主题

期刊订阅